Chemours reports Q3 adjusted EPS 20c, consensus 24c

Reports Q3 revenue $1.5B, consensus $1.5B. “Our consolidated results exceeded our expectations for the quarter, driven by continued strong demand for Opteon(TM) products, paired with a focus on enhancing operational excellence, driving stability in our operations to resolve disruptions, and ensure improved performance going forward,” said Denise Dignam, Chemours (CC) President and CEO. “While the broader macroeconomic environments we participate in continue to remain weak, we are focused on our strategic pillar execution where we continue to make notable progress.”